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SUMMARY
The aim of the study was the analysis of the frequency of HLA class I antigens in the Polish population of chil-
dren suffering from coeliac disease and their families, as well as the estimation of the relative risk of incidence,
etiologic fraction (EF) and preventive fraction (PF) indexes. Forty-six probands’ families were included in the
typing: 69 children with coeliac disease confirmed clinically and histologically, 49 healthy siblings and 91 par-
ents. The HLA antigens were typed with routine Terasaki an McClelland’s two-stage microcytotoxic assay in
NIH modification. The following antigens occurred significantly more frequently (p<0.0000...1) in phenotypes
of children with coeliac disease: HLA-A1 (c2 = 35.90; RR = 4.3; EF = 0.44), -B8 (c2 = 88.20; RR = 8.8; EF
= 0.58) and Cw7 (c2 = 55.24; RR = 7.5; EF = 0.69). The positive correlation for the specificity of HLA-A1, -
B8 was proved also in siblings (c2 = 16.03; c2 = 18.10) and parents (c2 = 15.67; c2 = 32.67). The presence of
antigens HLA-A1, -B8 in the phenotype may be the risk factor predisposing for the manifestation of hypersensi-
tivity to gluten.
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INTRODUCTION
The coeliac disease (CD) is caused by genetically
determined pathological immune response to con-
sumed gluten, specifically to gliadin and other pro-
lamines. The introduction of these proteins into
diet of a sensitive person results in clinical manifes-
tations of the malabsorption syndrome (primary
gluten intolerance) as well as characteristic histo-
logical changes of the mucous membrane of small
intestine (gluten-sensitive enteropathy) [1,2].
The studies on coeliac disease etiopathogenesis are
still being carries out, despite the fact that factor
responsible for its clinical manifestations is known.
Family studies showed that increased susceptibility
to coeliac disease was at least partially genetically
determined. The factor responsible for its inci-
dence was mapped on the short arm of 6th chro-
mosome in 6p23 segment [3,4]. Coeliac disease
was one of the first disease entities in which posi-
tive correlation with some of HLA region antigens
was observed. Genetic linkage and coeliac disease
associations with HLA system were the subject of
investigations in various countries [5—10]. The
results of these studies showed primarily the pres-
ence of associations with some of the antigens
determined by HLA-A and HLA-B loci. At present,
a strict correlation between primary gluten intoler-
ance and the presence of the following HLA class II
antigens has been proved: HLA-DQ2
(DQA1*0501, DQB1*0201) and HLA-DR3 (DRA,
DRB1*0301). The data that confirm the role of
genetic factor in etiopathogenesis of coeliac dis-
ease therefore attract researchers’ attention to
genes and the products of the Major
Histocompatibility Complex (MHC). Genes HLA-
DQA1 and DQB1 encode corresponding subunits
of the dimer presenting antigens on the surface of
T-lymphocyte immunocompetent cells.
The purpose of the study was the analysis of the
frequency of the HLA class I antigens in Polish
population of children with coeliac disease con-
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firmed clinically and histologically as well as in
their families.
MATERIAL AND METHODS
HLA-ABC antigen typing was conducted in 46 fam-
ilies, including 91 parents and 118 children (49
healthy siblings and 69 children suffering from the
disease, treated at the General Paediatric
Department of Silesian Medical University in
Zabrze and in 2nd Department of Paediatric
Diseases of Polish-American Paediatric Institute at
the Faculty of Medicine of Jagiellonian University
in Cracow. The diagnosis of the proband’s disease
was based on the criteria established in 1976 in
Interlaaken [1,2].
Human histocompatibility antigens of the HLA sys-
tem determined by HLA-ABC loci were typed with
the use of Terasaki and McClelland’s routine two-
step-microcytotoxic assay [11] in NIH modification
[12]. The typing included 14 specificities deter-
mined by HLA-A locus, 20 specificities determined
by HLA-B locus and biallelic Bw4/Bw6 system, as
well as 7 C-locus antigens. At least three different
anti-HLA sera were for the typing. They were
obtained from the Serum Bank of the National
Institute of Health in Bethesda, from the commer-
cial companies, and from the collection of
Independent Laboratory of Clinical Immunology of
the Faculty of Medicine of Jagiellonian University
in Cracow [13].
The control group for the frequency of HLA class I
antigens phenotypes was 1152 healthy adults of
both sexes living in the regions of Southern Poland
[14]. The phenotypes frequencies (f) were calculat-
ed with the use of the following equation
f = the number of people with the antigen present in
a given phenotype / the number of people examined
The frequency of HLA-ABC antigens in the exam-
ined group was compared to the results obtained
in control population with the use of chi-squared
test. In case of relatively small numbers, i.e. general
observation count below 100, Yates’ modification
was applied. H0 hypothesis of the absence of sig-
nificant differences between analysed groups was
rejected if the value of chi-squared test exceeded
the critical value of c20.05 (for a= 0.05) taken from
the table worked out by Hawkins [15]. The critical
value c20.05 for class I specific antigens for 43 tes-
ted equals 10.633.
The power of the association, i.e. the risk to develop
the disease in the population with a given HLA anti-
gen in comparison to the group without that antigen
was determined by calculating the relative risk value
(RR) according to Svejgaard et al. [16]. Etiologic frac-
HLA-A
antigens N f X2 N f X2 N f X2 N f
Children with coeliac disease Healthy siblings Parents Control population
A1
A2
A3
A9
A23(9)
A24(9)
A10
A25(10)
A26(10)
A11
A19
A29(19)
A30(19)
A31(19)
A32(19)
A33(19)
A68(28)
Ax
* p < 0.02 - 0.05; ** p < 0.01 - 0.001; *** p < 0.0001 - 0.0000...1
40
20
20
11
2
9
7
5
2
5
10
2
4
2
2
-
-
12
57.9710
28.9855
28.9855
15.9420
2.8986
13.0435
10.1449
7.2464
2.8986
7.2464
14.4928
2.8986
5.7971
2.8986
2.8986
-
-
35.90***
8.79*
0.32
2.89
0.60
1.57
3.19
0.41
2.47
0.92
0.13
0.08
0.05
0.49
0.04
-
-
25
16
10
8
2
6
9
9
-
3
12
6
2
-
3
1
1
10
51.0204
32.6531
20.4082
16.3265
4.0816
12.2449
18.3673
18.3673
-
6.1224
24.4898
12.2449
4.0816
-
6.1224
2.0408
2.0408
16.03***
3.89
0.34
1.78
0.05
1.32
0.00
2.33
-
0.98
0.70
11.35**
0.06
-
0.44
0.03
2.78
40
30
18
18
3
15
14
11
3
6
12
3
2
1
5
1
3
35
43.9560
32.9670
19.7802
19.7802
3.2967
16.4835
15.3846
12.0879
3.2967
6.5934
13.1868
3.2967
2.1978
1.0989
5.4945
1.0989
3.2967
15.67**
7.15
1.04
1.34
0.63
0.44
0.72
0.10
2.97
1.78
1.35
0.00
0.55
2.62
0.11
0.00
2.69
282
554
290
298
68
230
226
120
106
136
215
31
51
65
48
20
120
107
24.4792
48.0903
25.1736
25.8691
5.9027
19.9653
19.6181
10.4167
9.2014
11.8056
18.6632
2.6909
4.4271
5.6423
4.1667
1.7361
8.8542
Table 1. Frequency (f) of  HLA-A phenotypes in families of children with coeliac disease, and in the control population.
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tion index (EF) proposed by Green [17,18] was cal-
culated when RR values were greater than 1. EF
index was used to compare the number of people
with a given antigen to the frequency of the same
antigen in the whole population. EF index provides
information about the effect of a given antigen
(pathological factor) on the incidence of the disease.
In case of negative correlation, the preventive factor
index was calculated, in attempt to estimate the pro-
portion of cases with lower risk of disease develop-
ment due to the absence or low frequency of HLA
antigen in phenotype. The values of EF and PF
HLA-B
antigens N f X2 N f X2 N f X2 N f
Children with coeliac disease Healthy siblings Parents Control population
B7
B8
B13
B14
B15
B62(15)
B63(15)
B16
B38(16)
B39(16)
B18
B21
B49(21)
B50(21)
B27
B35
B41
B44(12)
B51(5)
B22
B55(22)
B56(22)
B57(17)
B60(40)
Bx
Bw4
Bw6
*** p < 0.0000...1
16
45
12
-
3
3
-
2
1
1
1
3
1
2
4
7
1
11
4
2
2
-
1
1
11
35
65
23.1884
65.2174
17..3913
-
4.3478
4.3478
-
2.8986
1.4493
1.4493
1.4493
4.3478
1.4493
2.8986
5.7971
10.1449
1.4493
15.9420
5.7971
2.8986
2.8986
-
1.4493
1.4493
50.7246
94.2029
0.49
88.20***
4.93
-
0.64
0.64
-
0.98
1.55
0.13
7.67
0.44
0.32
0.02
2.62
2.53
0.01
2.15
1.48
0.12
0.12
-
1.18
2.83
6.57
6.40
12
21
9
3
5
4
1
3
2
1
3
-
-
-
1
7
1
10
1
2
2
-
2
3
13
30
45
24.4898
42.8571
18.3673
6.1224
10.2041
8.1633
2.0408
6.1224
4.0816
2.0408
6.1224
-
-
-
2.0408
14.2857
2.0408
20.4082
2.0408
2.0408
2.0408
-
4.0816
6.1224
61.2245
91.8367
0.59
18.10***
4.24
0.02
0.05
0.03
0.17
0.13
0.03
0.00
1.76
-
-
-
4.35
0.31
0.10
0.23
4.13
0.00
0.00
-
0.11
0.01
0.39
2.77
18
39
13
7
7
6
1
5
4
1
3
3
2
1
6
16
1
11
9
3
2
1
2
3
30
50
77
19.7802
42.8571
14.2857
7.6923
7.6923
6.5934
1.0989
5.4945
4.3956
1.0989
3.2967
3.2967
2.1978
1.0989
6.5934
17.5824
1.0989
12.0879
9.8901
3.2967
2.1978
1.0989
2.1978
3.2967
54.9451
84.6154
0.00
32.67***
2.56
1.15
0.00
0.03
0.00
0.35
0.09
0.49
7.31
0.38
0.12
0.02
2.81
0.01
0.01
6.52
0.05
0.46
0.01
0.29
0.98
1.75
4.56
0.38
219
203
100
53
95
89
6
100
66
34
159
62
40
22
153
213
7
282
130
64
34
30
59
88
87
767
938
19.0104
17.6215
8.6806
4.6007
8.2465
7.7257
0.5208
8.6806
5.7292
2.9514
13.8021
5.3819
3.4722
1.9097
13.2813
18.4896
0.6076
24.4792
11.2847
5.5556
2.9514
2.6042
5.1215
7.6389
66.5799
81.4236
Table 2. Frequency (f) of  HLA-B phenotypes in families of children with coeliac disease, and in the control population .
HLA-C
antigens N f X2 N f X2 N f X2 N f
Children with coeliac disease Healthy siblings Parents Control population
Cw1
Cw2
Cw3
Cw4
Cw5
Cw6
Cw7
Cwx
*** p < 0.00001 - 0.0000...1
5
5
6
11
5
12
55
18
7.2464
7.2464
8.6957
15.9420
7.2464
17.3913
79.7101
0.01
2.56
3.72
2.20
0.03
0.00
55.24***
4
3
11
8
12
10
32
17
8.1633
6.1224
22.4490
16.3265
24.4898
20.4082
65.3061
0.04
2.30
0.02
1.32
17.68***
0.24
18.15***
14
15
14
20
9
14
51
34
15.3846
16.4835
15.3846
21.9780
9.8901
15.3846
56.0440
4.21
0.05
0.40
0.18
0.64
0.03
16.12***
97
173
215
283
81
192
397
106
8.4201
15.0174
18.6632
24.5660
7.0313
16.6667
34.4618
Table 3. Frequency (f) of  HLA-C phenotypes in families of children with coeliac disease, and in the control population. 
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indexes may range from 0 (no correlation) to 1.0
(maximum correlation).
When positive correlation was observed, i.e. there
was a statistically significant correlation, the etiolog-
ic fraction coefficient (EFe) proposed by Green was
calculated for the exposed people. In this way, the
proportion of cases with developed disease among
the population at risk could be estimated. In the
case of negative correlation, the preventive factor
coefficient (PFE) was calculated as the proportion of
cases protected in the exposure to people from the
whole population at risk of developing the disease.
RESULTS
The frequencies of HLA-ABC phenotypes in the
population of affected children, healthy siblings
and parents are presented in tables 1, 2, 3 along
with the results of the frequencies for the popula-
tion of 1152 healthy controls [14]. The analysis of
the frequencies of the antigens determined by
locus A indicates that the frequency of HLA-A1
antigen in the group of probands (c2 = 35.90,
p<0.000...1) is significantly higher, while the fre-
quency of HLA-A2 phenotypes is significantly
lower than in the control group (c2 = 8.79;
p<0.025).
The frequencies of HLA-A antigens also indicate
that there is a correlation (with high statistical sig-
nificance of the differences) between HLA-A1 in
parents (c2 = 15.67, p<0.001) and healthy siblings
(c2 = 16.03, p<0.0000...1) and, additionally, the
HLA-A29 antigen in healthy children (c2 = 11.35,
p<0.01) (table 1). Moreover, lower frequency of
HLA-A2 antigen was observed, with c2 values
equalling 7.15 and 3.89, respectively, and it
proved statistically insignificant according to
Hawkins’ table [15]. The frequency of the remain-
ing antigens determined by locus A was compara-
ble with control population in all examined groups.
Among the antigens determined by locus B, highly
significant differences were observed for the HLA-
B8 antigen (c2 = 88.20, p<0.0000...1) in children
with coeliac disease when compared to the results
obtained in control subjects. Positive correlation
for this specificity was also observed in healthy sib-
lings (c2 = 18.10, p<0.005) and parents (c2 =
32.67; p<0.0000...1). It was also found that in
probands’ families, HLA-B13 antigen occurred
more frequently (c2 = 2.56—4.93) when compared
to control group, but without statistical signifi-
cance. On the other hand, HLA-B18, -B27 and
—B44(12) antigens tended to occur less frequently
in phenotypes in all the analysed family members
than in healthy population (table 2).
Among locus C antigens, highly significant differ-
ences (p<0.0000...1) in comparison to the control
group were found for the HLA-Cw7 specificity.
The differences were observed with respect to chil-
dren with coeliac disease, siblings and parents.
Chi2 test value for them equalled 55.24, 18.15 and
17.04, respectively. In the group of children with
no manifestation of the pathological process, signif-
icantly higher frequency of HLA-Cw5 antigen was
also shown with c2 value = 17.68, p<0.00025
(table 3).
In the analysis of the relative risk of developing the
disease calculated for the antigens determined by
HLA
antigens
Relative risk RR
Etiologic fraction
Preventive fraction
EFe
PFE PF PFE PF PFE PF
EF EFe EF EFe EF
Children with coeliac
disease Healthy siblings Parents
A1
B8
Cw7
A29(19)
B13
Cw5
B18
B27
B44(12)
A1
B8
Cw7
A29(19)
B13
Cw5
A2
A23(9)
A26(10)
B18
B27
B44(12)
B38(16)
B57(17)
B60(40)
0.7650
0.8859
0.8662
1.0794
0.5485
0.0319
0.5278
0.5241
0.7054
0.8136
0.5982
0.3505
0.7580
0.7276
0.8222
0.4435
0.5778
0.6904
0.0736
0.0954
0.0019
0.2538
0.0310
0.0651
0.1124
0.0795
0.0859
0.0435
0.0375
0.0627
0.6888
0.7148
0.7207
0.8018
0.5775
0.7668
0.4766
0.3217
-
0.5927
0.8640
0.2089
0.2998
0.2117
0.2115
0.3514
0.3064
0.4707
0.0981
0.1061
0.1878
0.2292
0.0189
-
0.0818
0.1146
0.0511
0.0171
0.0108
0.0161
0.5867
0.7148
0.5876
0.1888
0.4296
0.3109
0.4691
0.8142
0.6636
0.7871
0.5391
0.5758
0.2435
0.5837
0.5878
0.2579
0.3064
0.3293
0.0062
0.0614
0.0307
0.2797
0.0462
0.0611
0.1088
0.0391
0.1409
0.0139
0.0298
0.0449
4.2553
8.7654
7.4712
1.0794
2.2147
1.0330
0.1864
0.4018
0.6495
3.2137
3.5062
3.5798
5.0458
2.3670
4.2883
0.4073
0.1360
0.7911
2.4197
3.5062
2.4247
1.2328
1.7533
1.4512
0.2129
0.4609
0.4242
Table 4. The relative risk (RR), etiologic (EFe, EF) and preventive
(PFe,PF) fraction of selected HLA class I antigens in families
of children with coeliac disease
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A, B and C loci, specificities HLA-A1, -B8 and Cw7
present in haplotype are deserve special attention
(table 4). The highest RR values were observed
mainly in the population of children with coeliac
disease and equalling 4.2553, 8.7654 and 7.4712,
for respective antigens. RR values related to the
frequency of these antigens in healthy siblings and
parents were lower, equalling 3.2137 and 2.4197
for HLA-A1, respectively. The values of relative risk
for the rest of the antigens determined by ABC loci
were lower than 1, except HLA-B13 and HLA-Cw5
specificities.
The analysis of etiologic fraction of HLA-ABC anti-
gens shows that calculated EF values corresponded
to the values of the relative risk (RR) of the disease.
When HLA-A1 antigen was inherited in the popu-
lation of affected children, the values of EFe and EF
were 0.7650 and 0.4435, respectively, and in the
case of inheriting HLA-B8, they were 0.8859 and
0.5778. The inclination for developing the disease
was estimated at 44.35% and 57.78%.
Similar comparison was drawn for the population
of mothers and fathers as well as healthy siblings.
Its outcomes are presented in table 4. The analysis
of EFe and EF shows that in case of HLA-A1, -B8, -
Cw7 antigen EF values in parents and siblings were
lower than those in affected children. Parental EF
of HLA-A1 antigen equalled 0.2579, while it was
0.3514 in healthy siblings. In affected children, EF
for the A1 antigen equalled 0.4435. Although in
the case of HLA-B8 specificity high values of EFe
and EF indexes were calculated (EFe = 0.8859,
EF=0.5778) for the group of children with the
manifestations of the disease, these values were
only slightly lower in their parents and siblings,
amounting to EFe = 0.7148, EF=0.3064, respec-
tively, in both analysed groups.
PFE values were high for HLA-A2, -B18, -B27, -
B44(12) antigens, ranging between 0.3505 and
0.8136 in affected children with low PF value
oscillating between 0.0795 and 0.2538. Similar
PFE values were calculated for healthy siblings
(0.2089-0.8640) and parents (0.4691-0.7871)
with equally low preventive factor index value.
High PFE values were also calculated for HLA-
A23(9), -A26(10), -B38(16), -B57(17) and -
B60(40) antigens. It referred mainly to the popu-
lation of affected children and their parents. This
may indicate the proportion of cases with this
particular antigen, protected in exposure to inci-
dence factors in relation to the whole hypotheti-
cal number of people who might develop the
disease.
DISCUSSION
The studies on the frequency of HLA antigens in
families of children suffering from coeliac disease
allowed to estimate the frequency of phenotypes
for specific HLA class I antigens. Statistical analysis
showed significantly higher frequency of HLA-A1, -
B8 (p<0.00001—0.0000...1) together with linked -
Cw7 antigen. The highest frequency was obtained
in affected children. Similar correlation (although
to lower extent) was discovered in parents and
healthy siblings. Additionally, significantly higher
frequencies of HLA-A29(19) and HLA-Cw5 pheno-
types were observed in affected children when
compared to control population.
Up to now, the calculation of the relative risk of
the disease (RR) was used as a rule, in order to esti-
mate the differences between HLA phenotypic
expression in the population of healthy and affect-
ed people. If the differences in the frequency of a
given HLA specificity were statistically significant
and RR values were high, it indicated a correlation
between HLA class I and class II antigens charac-
teristic for specific disease entity.
Svejgaard et al. [16] and Green [17,18] made an
attempt to express the relationship between the risk
of incidence and the index of ’incidence condensa-
tion’, etiologic fraction index and preventive frac-
tion index in mathematical terms. This is of particu-
lar importance in causative-heterogeneous diseases.
According to the authors, one can assume that the
effect of the dose of the gene determining disease
incidence is included in the value of calculated
fraction. The estimated RR values related to A1 and
B8 antigens proved low. They were approximately
twice as large in children with coeliac disease as in
the analysed group of parents and healthy siblings.
The highest relative risk of developing coeliac dis-
ease related to B8 antigen might have been secon-
darily determined by HLA-B8 and HLA-DR3 and
DR7 linkage disequilibrium effect [5,19,20].
Winklhofer-Roob et al. [20] presented an overview
of the frequency of antigens related to coeliac dis-
ease (i.e. HLA-B8, -DR3, -DR7) in 9 different pop-
ulations, without presenting HLA-B8 frequency in
three of them. This specificity was 2-3 times more
frequent in all the examined populations in com-
parison to control population. The frequency of
HLA-DR3 antigen was 2-4 times higher.
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The frequency of HLA antigens phenotypes in vari-
ous groups of family members was not a subject of
comprehensive analysis by Polish authors, except
for Siekiera’s studies published in 1992 [21]. The
author confirmed significantly more frequent
occurrence of HLA-A1, -B8, -DR3 antigens in phe-
notypes of patients with gluten malabsorption syn-
drome, analysing the determinations of the anti-
gens of HLA-ABC, DR system and other genetic
markers in 51 probands’ families. She pointed to a
correlation present with these antigens by the
analysis of antigens determined by A and B loci in
parents and healthy siblings. Lower frequency of
HLA-B17 antigen (c2 = 4.720) in parents and
twice more frequent HLA-B44(12) antigen (c2 =
3.514) observed by Siekiera were not confirmed in
this study. The frequencies of phenotypes of the
remaining HLA-ABC antigens in relation to healthy
population did not differ both in Siekiera’s studies
and in our analysis [22]. The only exceptions were
HLA-A29(19) and HLA-Cw5 antigens, observed
significantly more frequently in healthy siblings.
The comparison of the relative risk of disease inci-
dence calculated by Siekiera [21] and the one pre-
sented in this study shows that RR values for HLA-
A1 were similar and equalled 3.9565 and 4.2553,
respectively. On the other hand, the values for
HLA-B8 antigen were different and equalled
5.6040 and 8.7657. Johannsen [23] presented the
results quoted by eleven different authors, who
estimated the relative risk of developing coeliac
disease related to HLA-B8 antigen at 8.63 and it
was similar to the value estimated in this study.
The analysis of HLA-A and HLA-B frequencies car-
ried out by üukasik et al. [24] in the group of 107
children suffering from coeliac disease showed that
HLA-A1 and Ax antigens were more frequent in
affected children than in control population of
healthy people, while HLA-A3 and A-19 antigens
occurred less frequently. The relative risk equalled
3.5; 1.26; 0.41 and 0.45, respectively. Having per-
formed a statistical analysis, the authors did not
find any basis on which the hypothesis that the dif-
ference in frequencies of A1, A3 and Ax antigens
was statistically significant could have been reject-
ed. For the remaining locus A antigens including
wide specificity of HLA-A19, the difference proved
insignificant. Although Hetzel et al. [25] found pos-
itive a correlation between coeliac disease and
HLA-A23(9) antigen, the frequency of this specifici-
ty in examined group and their families was similar
to control population. De Marchi et al. [19] list
HLA-A30 and HLA-B13 among the antigens relat-
ed to coeliac disease as the ones with marked ten-
dency for increased frequency.
The distribution of HLA class I antigens frequency
in children suffering from coeliac disease and their
families seems to differ greatly. The association of
the positive associations between coeliac disease
and HLA class I antigens is still valid, because the
determination of their soluble form (sHLA) proved
significant [22]. Presently, it is a fact, that DQ2 par-
ticle plays a significant role in the pathogenesis of
coeliac disease as the restriction component for
gliadin-specific T lymphocytes in the alimentary
tract [26,27]. However, the question why and how
coeliac disease develops only in 20% of general
population of predisposed individuals with ’risk
alleles’ encoding DQ2 particles in their genome still
remains unanswered.
CONCLUSIONS
1. The presence of HLA-A1, -B8 antigens in phe-
notype may be a risk factor predisposing for the
manifestation of hypersensitivity to gluten.
2. The determination of these antigens can be
helpful for the problem of familial incidence of
the disease with different expression and clinical
course.
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